In contrast to non-malignant disorders such as Axenfeld-Rieger syndrome and Dandy-Walker syndrome—which are characterized by reduced normal FOXC1 function—the opposite appears generally true in cancer. This evidence concerns the gene FOXC1 and Axenfeld-Rieger syndrome.